Business Standard
Thursday, May 31, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||||||Technology| 
 Section Home | News Now | Features & Analysis | IT/ITES | Telecom | Hardware | Columnists | Gadgets & Gizmos
Home > Tech World Live Markets | Commodities
 

Persistent invests in personalised medicine
BS Reporter / Mumbai/ Pune Jul 02, 2011, 00:29 IST

Persistent Systems, a player in software product development services, has announced that the firm is partnering with Life Technologies Corporation, a global biotechnology tools company providing premier systems, consumables, and services in the molecular research and diagnostics space.

As part of the collaboration, Persistent said it will be co-investing with the Fragment and Sequence Genomics (FSG) division of Life Technologies to build sequencing and fragment analysis software platform.

BSE | NSE
Price  
Persistent Systems
The platform will be used for capillary electrophoresis instrumentation that will be submitted for FDA clearance or approval. According to the company, the solution represents an advanced genomic technology for clinics taking a step towards making personalised medicine a reality to combat critical human diseases like cancer. 

Persistent Systems will be working with Life Technologies to develop an integrated interpretation software and hardware solution that will intelligently use sequencing technology to analyse patient DNA samples through advanced, user-friendly software. As a technology partner, Persistent Systems will also be providing services to integrate assays from third party vendors.

"Today, molecular diagnostics is expanding beyond just the identification of infections and is recognised as an integral part of disease management and therapy. It is increasingly seen as the fastest growing segment in the in-vitro-diagnostics space with a market share predicted to reach 18 per cent by 2014," Persistent said in an official statement. "We are delighted to partner with Life Technologies in the personalised medicine and molecular diagnostics space. We believe that molecular diagnostics is an essential step to move towards personalised medicine and is vital for the future of healthcare industry. The diagnostics market holds great promise in the coming years and we are excited to extend our technology expertise and support to develop applications that are critical for saving lives," said Anand Deshpande, chairman and managing director, Persistent Systems.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end lower ahead of May F&O expiry
- Parsvnath posts Rs 23 cr loss in Q4
- Educomp net down 57% at Rs 61 cr in Jan-Mar qtr
- DLF Q4 net plunges 39% to Rs 211 cr
- Provogue Q4 net profit down 71% at Rs 1.81 cr
  Read Business news in 
- India's no. 1 Property Site. Click here to know more
- Help a Child Achieve her. Click to know more
- Watch The Film Here. Click here to know more..
- 1 billion in saving for Unilever without any tangles.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- 2 Lac Apartments, 1 Lac House / Plots. Click here
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Vodafone notice on arbitration premature: Govt
- Coal blocks for infrastructure projects get GoM nod
- Tata Motors skids as margins dip at JLR
- Wealthy clients turned tables on UBS and staff?
- Toyota looks at more small cars for India
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us